Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 2 days, and 1 more · Every feed →

All 47Congress 0Executive branch 0Insiders 47
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

PTCT · $50K+ · 47 trades

Trades
47
Buys 0 · Sells 47
People
9
Stocks
1
Disclosed value
$23.2M
range midpoints · Congress & executive
Filed late
4
  1. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$126Kdisclosed Oct 16 · filed 2 days after the trade
  2. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$155Kdisclosed Oct 9 · filed 2 days after the trade
  3. ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$105Kdisclosed Oct 7 · filed 2 days after the trade
  4. ▼ SELLGlenn Jr Md Phd Steele DirectorPTCT Ptc Therapeutics, Inc.$782Kdisclosed Oct 2 · filed 2 days after the trade
  5. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$199Kdisclosed Sep 18 · filed 2 days after the trade
  6. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$653Kdisclosed Sep 18 · filed 1 day after the trade
  7. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$472Kdisclosed Sep 18 · filed 2 days after the trade
  8. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$639Kdisclosed Sep 11 · filed 2 days after the trade
  9. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$673Kdisclosed Sep 11 · filed 1 day after the trade
  10. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$412Kdisclosed Aug 28 · filed 2 days after the trade
  11. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$500Kdisclosed Aug 28 · filed 2 days after the trade
  12. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$851Kdisclosed Aug 28 · filed 1 day after the trade
  13. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$172Kdisclosed Aug 21 · filed 1 day after the trade
  14. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$667Kdisclosed Aug 21 · filed 1 day after the trade
  15. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$389Kdisclosed Aug 21 · filed 2 days after the trade
  16. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$528Kdisclosed Aug 21 · filed 2 days after the trade
  17. ▼ SELLMichael Schmertzler DirectorPTCT Ptc Therapeutics, Inc.$50.4Kdisclosed Aug 21 · filed 1 day after the trade
  18. ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$70.6Kdisclosed Aug 19 · filed 2 days after the trade
  19. ▼ SELLMark Elliott Boulding Exec. VP and CLOPTCT Ptc Therapeutics, Inc.$133Kdisclosed Aug 19 · filed 2 days after the trade
  20. ▼ SELLMatthew B. Klein Chief Executive OfficerPTCT Ptc Therapeutics, Inc.$706Kdisclosed Aug 6 · filed 2 days after the trade
  21. ▼ SELLPierre Gravier Chief Financial OfficerPTCT Ptc Therapeutics, Inc.$281Kdisclosed Jul 16 · filed 2 days after the trade
  22. ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$222Kdisclosed Jul 13 · filed 4 days after the trade
  23. ▼ SELLMary L. Smith DirectorPTCT Ptc Therapeutics, Inc.$900Kdisclosed Jul 13 · filed 4 days after the trade
  24. ▼ SELLMary L. Smith DirectorPTCT Ptc Therapeutics, Inc.$525Kdisclosed Jul 13 · filed 4 days after the trade
  25. ▼ SELLNeil Gregory Almstead Chief Technical Ops OfficerPTCT Ptc Therapeutics, Inc.$345Kdisclosed Jul 8 · filed 1 day after the trade